Business Context and Reporting Period
This Form 8-K Current Report was filed by Akebia Therapeutics, Inc. on January 26, 2021. The filing discloses the appointment of Violetta Cotreau as the Company's principal accounting officer, effective January 26, 2021. David A. Spellman continues to serve as Senior Vice President, Chief Financial Officer, Treasurer, and principal financial officer.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on executive compensation and personnel changes.
Material Changes
The primary material change is the appointment of Violetta Cotreau as principal accounting officer. No financial performance changes or material events other than this personnel appointment are disclosed in this document.
Guidance, Outlook, and Compensation Details
The filing details the compensatory arrangements for Ms. Cotreau, effective from her initial employment in December 2020:
- Base Salary: $350,000 per year.
- Bonus Target: 35% of base salary.
- Signing Bonus: $60,000.
- Stock Options: 42,000 shares granted on December 31, 2020, with an exercise price of $2.80. Vesting occurs over four years (25% on the first anniversary, remaining 75% in equal quarterly installments).
- Restricted Stock Units (RSUs): 12,900 shares granted on December 31, 2020, vesting on the first anniversary of the grant date.
- Severance: In the event of termination without Cause or for Good Reason, Ms. Cotreau is entitled to nine months of base salary continuation.
The filing states there are no family relationships between Ms. Cotreau and any directors or executive officers, and no undisclosed transactions involving her.
Investor Verification Checklist
- Verify the vesting schedule and exercise price of the 42,000 stock options granted to Ms. Cotreau.
- Confirm the total equity value of the 12,900 RSUs based on the grant date stock price.
- Review the definitions of "Cause" and "Good Reason" in the Executive Severance Agreement to understand termination triggers.
- Check subsequent filings for any changes to the Company's principal accounting officer or financial reporting status.